[Progress of platelet derived grow factor family in non-small cell lung cancer].

about

[Progress of platelet derived grow factor family in non-small cell lung cancer].

Item

http://www.wikidata.org/entity/Q55464615

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

[Progress of platelet derived grow factor family in non-small cell lung cancer].

@en

[Progress of platelet derived grow factor family in non-small cell lung cancer].

@nl

type

Item

label

[Progress of platelet derived grow factor family in non-small cell lung cancer].

@en

[Progress of platelet derived grow factor family in non-small cell lung cancer].

@nl

prefLabel

[Progress of platelet derived grow factor family in non-small cell lung cancer].

@en

[Progress of platelet derived grow factor family in non-small cell lung cancer].

@nl

P1476

[Progress of platelet derived grow factor family in non-small cell lung cancer].

@en

P2093

Yijun Tian

http://www.w3.org/2001/XMLSchema#string

Yuan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Gleevec (STI-571) inhibits lung cancer cell growth (A549) and potentiates the cisplatin effect in vitro

Emerging roles of PDGF-D in EMT progression during tumorigenesis

Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.

Safety and efficacy of combining sunitinib with bevacizumab + paclitaxel/carboplatin in non-small cell lung cancer.

A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC).

Amplification of chromosomal segment 4q12 in non-small cell lung cancer

PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis.

A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer.

Platelet-derived growth factor signaling and human cancer.

P304

42-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2014.01.07

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Qian Chu

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24398313

http://www.w3.org/2001/XMLSchema#string

P932

6000208

http://www.w3.org/2001/XMLSchema#string